Evidence map›Paper›PMID 11865059›Full record

ArticleMolecular and cellular biology2002

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.

Ari Melnick, Graeme Carlile, K Farid Ahmad, Chih-Li Kiang, Connie Corcoran, Vivian Bardwell, Gilbert G Prive, Jonathan D Licht

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 212 citations in OpenAlex.

  1. Article
  2. A BACH1 inhibitor ameliorates myocardial infarction and limb ischemia in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  3. Article
  4. Article
  5. B Cell Lymphoma 6 (BCL6): A Conserved Regulator of Immunity and Beyond.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. The N-Terminal Part ofInternational journal of molecular sciences · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. B cell lymphoma 6A regulates immune development and function in zebrafish.Frontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Structural analysis of the PATZ1 BTB domain homodimer.Acta crystallographica. Section D, Structural biology · 2020
    Article
  19. Article
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ari MelnickDivision of Hematology, The Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, USA.
Graeme Carlile
K Farid Ahmad
Chih-Li Kiang
Connie Corcoran
Vivian Bardwell
Gilbert G Prive
Jonathan D Licht
Icahn School of Medicine at Mount Sinai · USUniversity of Minnesota · USUniversity of Toronto · CA

Funding

Molecular Basis of Action of the Putative Oncogene BCL6R01CA071540 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BARDWELL, VIVIAN J · 2002 to 2012
$3.0M
The PLZF Protein of t(11;17)-Promyelocytic LeukemiaR01CA059936 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LICHT, JONATHAN · 1993 to 2007
$2.9M
TRANSCRIPTIONAL REGULATION BY THE PLZF PROTEINK08CA073762 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI MELNICK, ARI M. · 1997 to 2001
$181k
MOLECULAR BASIS OF ACTION OF THE PUTATIVE ONCOGENE BCL6R29CA071540 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI BARDWELL, VIVIAN J · 1996 to 2000
$108k
NCI NIH HHS K08 CA 73762NCI NIH HHS R01 CA059936NCI NIH HHS R01 CA071540NCI NIH HHS R01 CA 59936NCI NIH HHS R29 CA071540NCI NIH HHS R29 CA 71540
6 · The paper itself

Abstract

The PLZF (promyelocytic leukemia zinc finger) transcriptional repressor, when fused to retinoic acid receptor alpha (RARalpha), causes a refractory form of acute promyelocytic leukemia. The highly conserved N-terminal BTB (bric a brac, tramtrack, broad complex)/POZ domain of PLZF plays a critical role in this disease, since it is required for transcriptional repression by the PLZF-RARalpha fusion protein. The crystal structure of the PLZF BTB domain revealed an obligate homodimer with a highly conserved charged pocket formed by apposition of the two monomers. An extensive structure-function analysis showed that the charged pocket motif plays a major role in transcriptional repression by PLZF. We found that mutations of the BTB domain that neutralize key charged pocket residues did not disrupt dimerization, yet abrogated the ability of PLZF to repress transcription and led to the loss of interaction with N-CoR, SMRT, and histone deacetylases (HDACs). We extended these studies to the Bcl-6 protein, which is linked to the pathogenesis of non-Hodgkin's lymphomas. In this case, neutralizing the charged pocket also resulted in loss of repression and corepressor binding. Experiments with purified protein showed that corepressor-BTB interactions were direct. A comparison of the PLZF, Bcl-6, and the FAZF (Fanconi anemia zinc finger)/ROG protein shows that variations in the BTB pocket result in differential affinity for corepressors, which predicts the potency of transcriptional repression. Thus, the BTB pocket represents a molecular structure involved in recruitment of transcriptional repression complexes to target promoters.

Indexed as

Amino Acid MotifsCell LineDimerizationDNA-Binding ProteinsHistone Deacetylase 1Histone DeacetylasesHumansKruppel-Like Transcription FactorsMolecular Sequence DataMutagenesis, Site-DirectedNuclear ProteinsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Promyelocytic Leukemia Zinc Finger ProteinProtein Structure, TertiaryProto-Oncogene ProteinsDNA-Binding ProteinsHDAC1 protein, humanHistone Deacetylase 1Histone DeacetylasesKruppel-Like Transcription FactorsNCOR1 protein, humanNCOR2 protein, humanNuclear ProteinsNuclear Receptor Co-Repressor 1Nuclear Receptor Co-Repressor 2Promyelocytic Leukemia Zinc Finger ProteinProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-6Repressor ProteinsTranscription FactorsZBTB16 protein, human

Identifiers

PMID11865059
PMCPMC135611
OpenAlexW2108166446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.